You sound like your complaining that big pharma wont be able to fleece the the US system for tons of money. Again why should US patients and insurance companies shoulder the burden of all the costs for the R&D of medicines?
U.S. consumers spend roughly three times as much on drugs as their European counterparts, and 90 percent more as a share of income. Calculations using publicly available aggregate data suggest that the United States market accounts for 64 to 78 percent of worldwide pharmaceutical profits. These profits drive drug innovation that ultimately benefits patients around the globe. While American subsidies to innovation provide much-needed philanthropy to poor countries, patients in richer countries outside the United States would benefit longer-term if they financed a greater share of drug discovery. Using a previously published economic-demographic microsimulation, we estimate that if European prices were 20 percent higher, the resulting increased innovation would generate $10 trillion in welfare gains for Americans, and $7.5 trillion for Europeans over the next 50 years. Encouraging other wealthy countries to shoulder more of the burden of drug discovery including higher prices for innovative treatments would ultimately benefit patients in the United States and the rest of the world. Download the full paper here.
https://schaeffer.usc.edu/research/global-burden-of-medical-innovation/
People complain that health care costs are too high in this country, medicine prices greatly add to that cost. My 78 yo mother pays about 200 bucks a month in co pays for her medicines, and thats with a state retirement health care system. Her state pension is 800 bucks.